Director/PDMR Shareholding

RNS Announcement

RNS Number : 6681E

GlaxoSmithKline PLC

19 July 2016

GlaxoSmithKline plc (the 'Company')

Transaction notification

Details of PDMR/person closely associated with them ('PCA')

Name

Mr D S Redfern

Position/status

Chief Strategy Officer

Initial notification/

amendment

Initial notification

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

Name

GlaxoSmithKline plc

LEI

5493000HZTVUYLO1D793

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted

Description of the financial instrument

Ordinary shares of 25 pence each ('Ordinary Shares')

ISIN: GB0009252882

Nature of the transaction

Increase in notional interest in Ordinary Shares following the re-investment of dividends paid to shareholders on 14 July 2016 on Ordinary Shares held in the Company's 2009 Deferred Annual Bonus Plan.

Price(s) and
volume(s)

Price(s)	Volume(s)
£16.285	54.852 (personal contribution)
£16.285	54.852 (personal contribution)
£16.285	68.250 (personal contribution)
£16.285	68.263 (personal contribution)
£16.285	102.730 (personal contribution)
£16.285	102.730 (personal contribution)
£16.285	54.852 (matching shares)
£16.285	54.852 (matching shares)
£16.285	68.250 (matching shares)
£16.285	68.263 (matching shares)
£16.285	102.730 (matching shares)
£16.285	102.730 (matching shares)

Aggregated information

Aggregated volume Price

903.354

£16.285

Date of the transaction

2016-07-14

Place of the transaction

n/a

This information is provided by RNS

The company news service from the London Stock Exchange

END

DSHKKLFFQDFXBBV

RNS metadata

Title: Director/PDMR Shareholding
Time: 08:00:06
Date: 20 Jul 2016
Category: Director/PDMR dealings
ID: 6681E